This site and event is intended for UK healthcare professionals
22 Nov 2022

Cardiovascular: Secondary prevention of CVD

Heart healthy lifestyle, supported by cardiac rehabilitation programmes and'appropriate pharmacotherapy are both important elements for on-going patient care.'

This session, using case studies drawn from everyday practice, will focus on the'pharmacological treatments for secondary prevention. For patients with an acute'coronary event many of the medicines will be commenced during the hospital'admission but will need on-going prescription, monitoring and review by the primary'care team and for patients with stable cardiovascular disease initation will be led by'the primary care team.'

Key Learning Points'

  • Describe the NICE guidelines for secondary prevention of cardiovascular disease'
  • Review a patient with established CVD to ensure the appropriate medicines have'been offered'
  • Describe the considerations for dose and /or treatment optimisation for a patient with'established CVD'
  • Consider where remote consultations may be used effectively to improve patient'management'
  • Discuss where a quality improvement (QI) initiative may improve patient care and'safe prescribing within a practice/PCN'

Presentation'

Q&A session

Downloadable content

Alison Warren's presentation pdf

Reflection record

Loading

Our speakers 2024

Our partners, sponsors and exhibitors 2024

Guidelines Live is an educational event made possible by sponsorship from organisations including pharmaceutical companies. Sponsors have had no input into the agenda of the meeting unless through sponsored session(s) as indicated on the main programme. A list of all sponsors can be found here.


 

Quick links